Correlation Between Cullinan Oncology and Connect Biopharma
Can any of the company-specific risk be diversified away by investing in both Cullinan Oncology and Connect Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cullinan Oncology and Connect Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cullinan Oncology LLC and Connect Biopharma Holdings, you can compare the effects of market volatilities on Cullinan Oncology and Connect Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cullinan Oncology with a short position of Connect Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cullinan Oncology and Connect Biopharma.
Diversification Opportunities for Cullinan Oncology and Connect Biopharma
0.67 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Cullinan and Connect is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Cullinan Oncology LLC and Connect Biopharma Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Connect Biopharma and Cullinan Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cullinan Oncology LLC are associated (or correlated) with Connect Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Connect Biopharma has no effect on the direction of Cullinan Oncology i.e., Cullinan Oncology and Connect Biopharma go up and down completely randomly.
Pair Corralation between Cullinan Oncology and Connect Biopharma
Given the investment horizon of 90 days Cullinan Oncology is expected to generate 3.24 times less return on investment than Connect Biopharma. But when comparing it to its historical volatility, Cullinan Oncology LLC is 1.86 times less risky than Connect Biopharma. It trades about 0.02 of its potential returns per unit of risk. Connect Biopharma Holdings is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 87.00 in Connect Biopharma Holdings on September 4, 2024 and sell it today you would earn a total of 21.00 from holding Connect Biopharma Holdings or generate 24.14% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cullinan Oncology LLC vs. Connect Biopharma Holdings
Performance |
| Timeline |
| Cullinan Oncology LLC |
| Connect Biopharma |
Cullinan Oncology and Connect Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cullinan Oncology and Connect Biopharma
The main advantage of trading using opposite Cullinan Oncology and Connect Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cullinan Oncology position performs unexpectedly, Connect Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Connect Biopharma will offset losses from the drop in Connect Biopharma's long position.| Cullinan Oncology vs. Bolt Biotherapeutics | Cullinan Oncology vs. Day One Biopharmaceuticals | Cullinan Oncology vs. Lyra Therapeutics | Cullinan Oncology vs. Autolus Therapeutics |
| Connect Biopharma vs. Assembly Biosciences | Connect Biopharma vs. Instil Bio | Connect Biopharma vs. CytomX Therapeutics | Connect Biopharma vs. Achilles Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |